Disclosures for "Examining Rates of Pseudoprogression in Older Patients with Glioblastoma"
-
Mr. Chien has nothing to disclose.
-
Dr. Hardy has received research support from the American Cancer Society.
-
Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
-
Dr. Mohile has nothing to disclose.
-
Dr. Hemminger has nothing to disclose.